The Value of Mitotic Count and Ki67 Proliferation Index in Congenital Mesoblastic Nephroma

Fetal Pediatr Pathol. 2016;35(6):376-384. doi: 10.1080/15513815.2016.1207731. Epub 2016 Aug 2.

Abstract

Objective: We aimed to define the histopathologic features and proliferative rate of congenital mesoblastic nephroma (CMN) as a risk factor for recurrence.

Methods: Fourteen cases of CMN among 138 registered pediatric renal tumors were retrospectively reviewed. The prognostic impact for mitotic rate and Ki67 index was investigated.

Results: There were four (28.6%) classic, six (42.9%) cellular, and four (28.6%) mixed type CMNs, with average Ki-67 counts of 16.75% in the classic CMN, and 53.2% in the tumors with cellular components (both mixed and cellular CMNs). Twelve patients (85.7%) were aged less than six months. Tumors with cellular component showed significantly larger tumor diameter and higher Ki-67 index (p = 0.015 and p = 0.016, respectively). The patient with cellular CMN, whose tumor showed the highest mitotic rate (4.9/HPF), but not the highest Ki67 index (57.4%), died of recurrent disease with distant metastasis.

Conclusion: Proliferative markers-mitotic count and Ki67 index-have limited value to predict recurrence or metastasis in CMNs with a cellular component.

Keywords: Ki-67; mesoblastic nephroma; mitosis; pediatric; renal tumor.

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • DNA-Binding Proteins / metabolism
  • Female
  • Fibrosarcoma / metabolism
  • Fibrosarcoma / pathology*
  • Humans
  • Infant
  • Infant, Newborn
  • Ki-67 Antigen / metabolism*
  • Kidney Neoplasms / pathology*
  • Male
  • Mitosis
  • Nephroma, Mesoblastic / pathology*
  • Receptor Protein-Tyrosine Kinases / metabolism
  • Repressor Proteins / metabolism
  • Transcription Factors / metabolism

Substances

  • DNA-Binding Proteins
  • Ki-67 Antigen
  • Repressor Proteins
  • Transcription Factors
  • Receptor Protein-Tyrosine Kinases